Visugromab is an experimental medication being studied for treating non-small cell lung cancer. It works by targeting specific proteins that may help fight cancer cells.

Nivolumab is a type of immunotherapy medication that helps the body’s immune system recognize and fight cancer cells. It works by blocking certain proteins that prevent the immune system from attacking cancer cells.

Docetaxel is a chemotherapy medication used to treat various types of cancer, including lung cancer. It works by interfering with the growth and spread of cancer cells in the body.

Non-small cell lung cancer (NSCLC) – A type of lung cancer that begins in the larger lung cells and grows more slowly than small cell lung cancer. When the cancer spreads beyond the lungs to other parts of the body, it is called metastatic non-squamous NSCLC. The disease typically develops in the cells that line the air passages in the lungs, with non-squamous types including adenocarcinoma and large cell carcinoma. As the disease progresses, cancer cells can break away from the primary tumor and spread through the bloodstream or lymphatic system to other organs. The condition affects the lungs’ ability to function normally and can impact breathing and oxygen exchange.